Expression of interleukin-1β and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits

Shing Jong Lin, Hui Tzu Yen, Yung Hsiang Chen, Hung Hai Ku, Feng Yen Lin, Yuh Lien Chen

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The migration of vascular smooth muscle cells (VSMCs) from the media to the intima and the proliferation of intimal VSMCs are key events in restenotic lesion development. These events, which are preceded and accompanied by inflammation, are modulated by the proinflammatory cytokine, interleukin-1β (IL-1β), which induces vascular smooth muscle cells to express adhesion molecules and to proliferate. IL-1β action is complex and regulated, in part, by its naturally occurring inhibitor, the IL-1 receptor antagonist (IL-1ra). Whether there was a temporal and spatial correlation between IL-1β and IL-1ra expression in, and release by, oxidized low density lipoproteins (oxLDL)-stimulated human aortic smooth muscle cells (HASMCs) was determined by using ELISA and Western blot. In addition, IL-1β and IL-1ra expression was detected in the neointima of endothelia-denuded cholesterol-fed New Zealand white rabbits by immunohistochemistry and Western blot. In HASMCs, oxLDL induced IL-1β and IL-1ra expression and release in a dose- and time-dependent manner. Treatment with 20 μg/ml oxLDL resulted in increased IL-1β release after 6 h, which peaked at 24 h, and in increased IL-1ra release, first seen after 12 h, but continuing to increase for at least 48 h. In the cells, IL-β expression showed a similar pattern to release, whereas IL-1ra expression was seen in unstimulated cells and was not increased by oxLDL treatment. Confocal microscopy showed colocalization of IL-β and IL-1ra expression in oxLDL-stimulated HASMCs. oxLDL caused significant induction of nuclear factor kappa B and activator protein-1 DNA binding activity in HASMCs (6.6- and 3.3-fold, respectively). In cholesterol-fed endothelia-denuded rabbits, the notably thickened intima showed significant IL-1β and IL-1ra expression. These results provide further support for the role of IL-1 system in the pathogenesis of restenosis. This is the first demonstration of IL-1β and IL-1ra expression and secretion of oxLDL-treated HASMCs and their expression in the rabbit neointima, suggesting that the smooth muscle cells of the intima are an important source of these factors.

Original languageEnglish
Pages (from-to)836-847
Number of pages12
JournalJournal of Cellular Biochemistry
Volume88
Issue number4
DOIs
Publication statusPublished - Mar 1 2003
Externally publishedYes

Fingerprint

Neointima
Interleukin-1 Receptors
Interleukin-1
Smooth Muscle Myocytes
Endothelium
Muscle
Cholesterol
Cells
Rabbits
Vascular Smooth Muscle
Western Blotting
Tunica Intima
oxidized low density lipoprotein
NF-kappa B
Confocal microscopy
Transcription Factor AP-1
Human Activities
Confocal Microscopy
Demonstrations
Adhesion

Keywords

  • IL-1β
  • IL-1ra
  • Inflammation
  • Restenosis
  • Smooth muscle cells

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Expression of interleukin-1β and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits. / Lin, Shing Jong; Yen, Hui Tzu; Chen, Yung Hsiang; Ku, Hung Hai; Lin, Feng Yen; Chen, Yuh Lien.

In: Journal of Cellular Biochemistry, Vol. 88, No. 4, 01.03.2003, p. 836-847.

Research output: Contribution to journalArticle

@article{f34c3c76116d4b69bebda25253fb6b58,
title = "Expression of interleukin-1β and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits",
abstract = "The migration of vascular smooth muscle cells (VSMCs) from the media to the intima and the proliferation of intimal VSMCs are key events in restenotic lesion development. These events, which are preceded and accompanied by inflammation, are modulated by the proinflammatory cytokine, interleukin-1β (IL-1β), which induces vascular smooth muscle cells to express adhesion molecules and to proliferate. IL-1β action is complex and regulated, in part, by its naturally occurring inhibitor, the IL-1 receptor antagonist (IL-1ra). Whether there was a temporal and spatial correlation between IL-1β and IL-1ra expression in, and release by, oxidized low density lipoproteins (oxLDL)-stimulated human aortic smooth muscle cells (HASMCs) was determined by using ELISA and Western blot. In addition, IL-1β and IL-1ra expression was detected in the neointima of endothelia-denuded cholesterol-fed New Zealand white rabbits by immunohistochemistry and Western blot. In HASMCs, oxLDL induced IL-1β and IL-1ra expression and release in a dose- and time-dependent manner. Treatment with 20 μg/ml oxLDL resulted in increased IL-1β release after 6 h, which peaked at 24 h, and in increased IL-1ra release, first seen after 12 h, but continuing to increase for at least 48 h. In the cells, IL-β expression showed a similar pattern to release, whereas IL-1ra expression was seen in unstimulated cells and was not increased by oxLDL treatment. Confocal microscopy showed colocalization of IL-β and IL-1ra expression in oxLDL-stimulated HASMCs. oxLDL caused significant induction of nuclear factor kappa B and activator protein-1 DNA binding activity in HASMCs (6.6- and 3.3-fold, respectively). In cholesterol-fed endothelia-denuded rabbits, the notably thickened intima showed significant IL-1β and IL-1ra expression. These results provide further support for the role of IL-1 system in the pathogenesis of restenosis. This is the first demonstration of IL-1β and IL-1ra expression and secretion of oxLDL-treated HASMCs and their expression in the rabbit neointima, suggesting that the smooth muscle cells of the intima are an important source of these factors.",
keywords = "IL-1β, IL-1ra, Inflammation, Restenosis, Smooth muscle cells",
author = "Lin, {Shing Jong} and Yen, {Hui Tzu} and Chen, {Yung Hsiang} and Ku, {Hung Hai} and Lin, {Feng Yen} and Chen, {Yuh Lien}",
year = "2003",
month = "3",
day = "1",
doi = "10.1002/jcb.10431",
language = "English",
volume = "88",
pages = "836--847",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Expression of interleukin-1β and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits

AU - Lin, Shing Jong

AU - Yen, Hui Tzu

AU - Chen, Yung Hsiang

AU - Ku, Hung Hai

AU - Lin, Feng Yen

AU - Chen, Yuh Lien

PY - 2003/3/1

Y1 - 2003/3/1

N2 - The migration of vascular smooth muscle cells (VSMCs) from the media to the intima and the proliferation of intimal VSMCs are key events in restenotic lesion development. These events, which are preceded and accompanied by inflammation, are modulated by the proinflammatory cytokine, interleukin-1β (IL-1β), which induces vascular smooth muscle cells to express adhesion molecules and to proliferate. IL-1β action is complex and regulated, in part, by its naturally occurring inhibitor, the IL-1 receptor antagonist (IL-1ra). Whether there was a temporal and spatial correlation between IL-1β and IL-1ra expression in, and release by, oxidized low density lipoproteins (oxLDL)-stimulated human aortic smooth muscle cells (HASMCs) was determined by using ELISA and Western blot. In addition, IL-1β and IL-1ra expression was detected in the neointima of endothelia-denuded cholesterol-fed New Zealand white rabbits by immunohistochemistry and Western blot. In HASMCs, oxLDL induced IL-1β and IL-1ra expression and release in a dose- and time-dependent manner. Treatment with 20 μg/ml oxLDL resulted in increased IL-1β release after 6 h, which peaked at 24 h, and in increased IL-1ra release, first seen after 12 h, but continuing to increase for at least 48 h. In the cells, IL-β expression showed a similar pattern to release, whereas IL-1ra expression was seen in unstimulated cells and was not increased by oxLDL treatment. Confocal microscopy showed colocalization of IL-β and IL-1ra expression in oxLDL-stimulated HASMCs. oxLDL caused significant induction of nuclear factor kappa B and activator protein-1 DNA binding activity in HASMCs (6.6- and 3.3-fold, respectively). In cholesterol-fed endothelia-denuded rabbits, the notably thickened intima showed significant IL-1β and IL-1ra expression. These results provide further support for the role of IL-1 system in the pathogenesis of restenosis. This is the first demonstration of IL-1β and IL-1ra expression and secretion of oxLDL-treated HASMCs and their expression in the rabbit neointima, suggesting that the smooth muscle cells of the intima are an important source of these factors.

AB - The migration of vascular smooth muscle cells (VSMCs) from the media to the intima and the proliferation of intimal VSMCs are key events in restenotic lesion development. These events, which are preceded and accompanied by inflammation, are modulated by the proinflammatory cytokine, interleukin-1β (IL-1β), which induces vascular smooth muscle cells to express adhesion molecules and to proliferate. IL-1β action is complex and regulated, in part, by its naturally occurring inhibitor, the IL-1 receptor antagonist (IL-1ra). Whether there was a temporal and spatial correlation between IL-1β and IL-1ra expression in, and release by, oxidized low density lipoproteins (oxLDL)-stimulated human aortic smooth muscle cells (HASMCs) was determined by using ELISA and Western blot. In addition, IL-1β and IL-1ra expression was detected in the neointima of endothelia-denuded cholesterol-fed New Zealand white rabbits by immunohistochemistry and Western blot. In HASMCs, oxLDL induced IL-1β and IL-1ra expression and release in a dose- and time-dependent manner. Treatment with 20 μg/ml oxLDL resulted in increased IL-1β release after 6 h, which peaked at 24 h, and in increased IL-1ra release, first seen after 12 h, but continuing to increase for at least 48 h. In the cells, IL-β expression showed a similar pattern to release, whereas IL-1ra expression was seen in unstimulated cells and was not increased by oxLDL treatment. Confocal microscopy showed colocalization of IL-β and IL-1ra expression in oxLDL-stimulated HASMCs. oxLDL caused significant induction of nuclear factor kappa B and activator protein-1 DNA binding activity in HASMCs (6.6- and 3.3-fold, respectively). In cholesterol-fed endothelia-denuded rabbits, the notably thickened intima showed significant IL-1β and IL-1ra expression. These results provide further support for the role of IL-1 system in the pathogenesis of restenosis. This is the first demonstration of IL-1β and IL-1ra expression and secretion of oxLDL-treated HASMCs and their expression in the rabbit neointima, suggesting that the smooth muscle cells of the intima are an important source of these factors.

KW - IL-1β

KW - IL-1ra

KW - Inflammation

KW - Restenosis

KW - Smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=0037371060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037371060&partnerID=8YFLogxK

U2 - 10.1002/jcb.10431

DO - 10.1002/jcb.10431

M3 - Article

C2 - 12577317

AN - SCOPUS:0037371060

VL - 88

SP - 836

EP - 847

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 4

ER -